Related Experiment Video
Updated: Jul 26, 2026

08:30
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
Published on: April 19, 2011
Ischemic preconditioning - an opiate constitutive nitric oxide molecular hypothesis
G B Stefano1, K Neenan, P Cadet
1Neuroscience Research Institute, State University of New York College at Old Westbury, Old Westbury, New York 11568, USA. stefanog@surg.som.sunysb.edu
Summary
Transient ischemia may protect the heart by mimicking exercise responses. This process, involving nitric oxide, down-regulates cellular activity, offering protection against sustained cardiac insults.
Area of Science:
- Cardiovascular Physiology
- Cellular Signaling
Background:
- Coronary artery disease is the leading cause of adult mortality in the US.
- Transient ischemia is being investigated for its potential to precondition the myocardium.
- Myocardial preconditioning may involve endogenous physiological processes.
Purpose of the Study:
- To review the speculative role of ischemic preconditioning in protecting the myocardium.
- To propose that ischemic preconditioning is linked to physiological processes associated with exercise.
- To explore the involvement of nitric oxide, opiates, and opioids in myocardial protection.
Main Methods:
- Speculative review of existing literature.
- Analysis of cellular responses to transient ischemia and metabolic demand.
- Examination of signaling pathways involving nitric oxide synthase, opiates, and opioids.
Main Results:
- Transient ischemia mimics cellular responses to normal metabolic ATP dips.
- Constitutive nitric oxide synthase-derived nitric oxide down-regulates cellular excitatory states.
- Opiate and opioid signaling may contribute to protection by releasing nitric oxide.
Conclusions:
- Ischemic preconditioning protection likely arises from an existing physiological process linked to exercise.
- Endogenous nitric oxide stimulators protect by engaging a process that limits activation after physical exertion.
- Nitric oxide plays a key role in dampening cellular activity for protection against ischemic insults.
Related Concept Videos
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

